Search Results - "Stollenwerk, B"

Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan by Hagino, H., Tanaka, K., Silverman, S., McClung, M., Gandra, S. R., Charokopou, M., Adachi, K., Johnson, B., Stollenwerk, B.

“…Summary This study assessed the cost effectiveness of romosozumab versus teriparatide, both sequenced to alendronate, for the treatment of severe…”
Get full text

Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom by Svedbom, A., Hadji, P., Hernlund, E., Thoren, R., McCloskey, E., Stad, R., Stollenwerk, B.

“…Summary This study estimated the cost-effectiveness of pharmacological fracture prevention as prescribed in the five largest European countries (EU5) using the…”
Get full text

A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis by Söreskog, E., Borgström, F., Lindberg, I., Ström, O., Willems, D., Libanati, C., Kanis, J. A., Stollenwerk, B., Charokopou, M.

“…Summary A novel cost-effectiveness model framework was developed to incorporate the elevated fracture risk associated with a recent fracture and to allow…”
Get full text

Cost-effectiveness of hip protector use on a geriatric ward in Germany: a Markov model by Stollenwerk, B., Bartmus, T., Klug, F., Stock, S., Müller, D.

“…Summary In this study, we determined the cost-effectiveness of hip protector use compared with no hip protector on a geriatric ward in Germany. From both the…”
Get full text

Risk Factors for Long-Term Vancomycin-Resistant Enterococci Persistence-A Prospective Longitudinal Study by Correa-Martinez, Carlos L, Stollenwerk, Verena B, Kossow, Annelene, Schaumburg, Frieder, Mellmann, Alexander, Kampmeier, Stefanie

“…Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens that require effective infection control measures, representing a challenge for…”
Get full text

The association between health system development and the burden of cardiovascular disease: an analysis of WHO country profiles by Liu, Yanmei, Dalal, Koustuv, Stollenwerk, Björn

“…Several risk factors for cardiovascular disease (CVD) have been identified in recent decades. However, the association between the health system and the burden…”
Get full text

Limited Economic Evidence of Carotid Artery Stenosis Diagnosis and Treatment: A Systematic Review by Shenoy, A.U, Aljutaili, M, Stollenwerk, B

“…Abstract The objective of this article is to assess the availability and validity of economic evaluations of carotid artery stenosis (CS) diagnosis and…”
Get full text

Cost-Utility of Active Surveillance for the Treatment of Localized Prostate Cancer in the Context of the German Health Care System by Koerber, F, Waidelich, R, Stollenwerk, B, Rogowski, W

Get full text

Cost-Effectiveness Analysis of Ugt1a1 Genotyping Before Colorectal Cancer Treatment with Irinotecan by Butzke, B, Oduncu, F, Heinemann, V, Pfeufer, A, Giessen, C, Stollenwerk, B, Rogowski, W

Get full text

RE4 Beyond the Evidence - The Influence of Decision Processes on Outcomes in Coverage Determination of Health Technologies by Fischer, K.E, Rogowski, W.H, Leidl, R, Stollenwerk, B

Get full text

A Societal Perspective Cost-Utility Analysis of Rivaroxaban Compared with Enoxaparin Sodium in Patients Undergoing Total Hip or Total Knee Replacement Surgery by Stollenwerk, B, Le, L, Zindel, S, Müller, D, Klug, F, Stock, S

Get full text

Prioritization of Future Outcomes Research Studies in Chronic Myeloid Leukemia: Value of Information Analysis by Rochau, U, Kühne, F, Jahn, B, Kurzthaler, C, Corro, Ramos I, Chhatwal, J, Stollenwerk, B, Goldhaber-Fiebert, J.D, Siebert, U

Get full text

PRM21 Communicating to Decision Makers the Parameter Uncertainty in the IQWiG Efficiency Frontier Approach by Stollenwerk, B, Briggs, A, Fenwick, E, Caro, J.J, Siebert, U, Lhachimi, S.K, Gerber, A

Get full text

RWD87 Real-World Treatment Patterns, Healthcare Costs, and Healthcare Resource Utilization in Patients in the US With Metastatic Non-Small Cell Lung Cancer Receiving Systemic Anticancer Therapy by Chopra, D, Waterhouse, DM, Sultan, I, Lonshteyn, A, Delea, TE, Stollenwerk, B

Get full text

PCV1 Modeling the Clinical Consequences of Delayed Initiation of Evolocumab Due to Payer Restrictions in Patients with a Recent Myocardial Infarction by Hagström, E., Martinez, L., Stollenwerk, B., Papadakis, K., Villa, G.

Get full text

Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients by Zech, Detlev F J, Grond, Stefan U A, Lynch, John, Dauer, Hans G, Stollenwerk, Bernd, Lehmann, Klaus A

“…This pilot study evaluated the efficacy and side effects of a combination of initial patient-controlled analgesia (PCA) for dose-finding with transdermal…”
Get more information

Exploring The Potential Value of Improved Care for Secondary Hyperparathyroidism (SHPT) with A Novel Investigational Calcimimetic Therapy by Stollenwerk, B, Iannazzo, S, Cooper, K, Belozeroff, V

Get full text

PUK17 - Exploring The Potential Value of Improved Care for Secondary Hyperparathyroidism (SHPT) with A Novel Investigational Calcimimetic Therapy by Stollenwerk, B, Iannazzo, S, Cooper, K, Belozeroff, V

Get full text

PMS43 - AN ECONOMIC VALUE FRAMEWORK TO ASSESS THE COST EFFECTIVENESS OF FRACTURE PREVENTION TREATMENTS IN PATIENTS WITH OSTEOPOROSIS AT IMMINENT RISK OF FRACTURE by Jonsson, E., Borgström, F., Ström, O., Toth, E., Libanati, C., Stollenwerk, B., Kanis, J.A., Charokopou, M.

Get full text

PCV57 A Systematic Literature Review of Cost-Utility Analyses of PCSK9 Inhibitors by Villa, G., Postma, M., Heeg, B., Kroi, F., Sidelnikov, E., Gomez Montero, M., Abbas, Z., Hashim, M., Stollenwerk, B., Fonarow, G.C.

Get full text